Cognitive function and quality of life after surgery for early breast cancer in North Jutland, Denmark

References

• Danish Breast Cancer Cooporative Group. Danish Breast Cancer Cooporative Group. available from, , http:\\www dbcg dk+retningslinier2007, 2004 [ cited 2008].
   Google Scholar
• Jenkins, V, Shilling, V, Deutsch, G, Bloomfield, D, Morris, R, Allan, S, , et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 2006.
   Google Scholar
• Wieneke MH, Dienst E. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psychooncology 1995; 4: 61–6
   Web of Science ®Google Scholar
• Cimprich B, So H, Ronis DL, Trask C. Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer. Psychooncology 2005; 14: 70–8
   PubMed Web of Science ®Google Scholar
• Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA. ‘Chemobrain’ in breast carcinoma?: A prologue’. Cancer 2004; 101: 466–75
   PubMed Web of Science ®Google Scholar
• Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, et al. Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology 2006; 15: 422–30
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365–76
   PubMed Web of Science ®Google Scholar
• Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A. The EORTC QLQ-C30 Scoring Manual3rd ed. European Organisation for Research and Treatment of Cancer, Brussels 2001
   Google Scholar
• Schwarzer R, Jerusalem M. Measures in health psychology: A user's portfolio. Causal and control beliefs. Generalised self-efficacy scale1st ed, J Weinman, S Wright, M Johnston. Nfer-Nelson, WindsorUK 1995; 35–7
   Google Scholar
• Luszczynska A, Gutiérrez-Doña B, Schwarzer R. General self-efficacy in various domains of human functioning: Evidence from five countries. Inter J Psychol 2005; 40: 80–9
   Web of Science ®Google Scholar
• McNair DM, Loor M, Droppleman LF. Profile of mood states. Educational and Industrial Testing Service, San Diego, CA 1981
   Google Scholar
• ISPOC. International study on postoperative cognitive dysfunction. Available from, , http:\\www.sps.ele.tue.nl/ispocd/index.html. March, 2006, 13 [ cited 2008].
   Google Scholar
• Nelson HE, O'Connell A. Dementia: The estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex 1978; 14: 234–44
   PubMed Web of Science ®Google Scholar
• Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J, et al. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet 1998; 351: 857–61
   PubMed Web of Science ®Google Scholar
• Johnson T, Monk T, Rasmussen LS, Abildstrom H, Houx P, Korttila K, et al. Postoperative cognitive dysfunction in middle-aged patients. Anesthesiology 2002; 96: 1351–7
   PubMed Web of Science ®Google Scholar
• Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I, et al. Cognitive function during neoadjuvant chemotherapy for breast cancer: Results of a prospective, multicenter, longitudinal study. Cancer 2007; 109: 1905–13
   PubMed Web of Science ®Google Scholar
• Schagen SB, Muller MJ, Boogerd W, Mellenbergh GJ, van Dam FS. Change in cognitive function after chemotherapy: A prospective longitudinal study in breast cancer patients. J Natl Cancer Inst 2006; 98: 1742–5
   PubMed Web of Science ®Google Scholar
• Ahles, TA, Saykin, AJ, McDonald, BC, Furstenberg, CT, Cole, BF, Hanscom, BS, , et al. Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat 2007;[ Epub ahead of print].
   PubMedGoogle Scholar
• Bender CM, Ergyn FS, Rosenzweig MQ, Cohen SM, Sereika SM. Symptom clusters in breast cancer across 3 phases of the disease. Cancer Nurs 2005; 28: 219–25
   PubMedGoogle Scholar
• van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd WE, Droogleever Fortuyn ME, et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. J Natl Cancer Inst 1998; 90: 210–8
   PubMed Web of Science ®Google Scholar
• Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: Five year observational cohort study. BMJ 2005; 330: 702
   PubMed Web of Science ®Google Scholar
• Nyenhuis DL, Yamamoto C, Luchetta T, Terrien A, Parmentier A. Adult and geriatric normative data and validation of the profile of mood states. J Clin Psychol 1999; 55: 79–86
   PubMed Web of Science ®Google Scholar
• Brandberg Y, Michelson H, Nilsson B, Bolund C, Erikstein B, Hietanen P, et al. Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epirubicin, and cyclophosphamide. Scandinavian Breast Group Study 9401. J Clin Oncol 2003; 21: 3659–64
   PubMed Web of Science ®Google Scholar
• Schou I, Ekeberg O, Sandvik L, Hjermstad MJ, Ruland CM. Multiple predictors of health-related quality of life in early stage breast cancer. Data from a year follow-up study compared with the general population. Qual Life Res 2005; 14: 1813–23
   PubMed Web of Science ®Google Scholar
• Dano H, Andersen O, Ewertz M, Petersen JH, Lynge E. Socioeconomic status and breast cancer in Denmark. Int J Epidemiol 2003; 32: 218–24
   PubMedGoogle Scholar
• Ewertz M, Mellemkjaer L, Poulsen AH, Friis S, Sorensen HT, Pedersen L, et al. Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study. Br J Cancer 2005; 92: 1293–7
   PubMed Web of Science ®Google Scholar